Dual GLP-1 and GIP receptor agonist for powerful appetite suppression, fat loss and metabolic improvement.

Product Overview

Tirzepatide 30mg activates dual GLP-1 and GIP hormone pathways for powerful appetite suppression and metabolic improvement. GLP-1 increases satiety and reduces food intake; GIP amplifies insulin response and enhances fat oxidation. Ideal for physician-supervised weight loss and clients transitioning from semaglutide.

Composition

Tirzepatide 30mg

Strength & Volume

30mg | 2mL

Dosing System

200-click pen system

Per Click/Unit

0.15mg per click

Beginner Dose

10 units (1.5mg) Week 1

Standard Dose

50 units (7.5mg)

Max Dose

2 x 40 units (12mg)

Frequency

Once weekly — DO NOT inject more than once per week

Cycle Length & Off Period

Ongoing with escalation protocol | Off Period: N/A

Key Benefits

Expected Outcomes

Better control of hunger signals / reduction in body weight and BMI / improved blood glucose stability / increased fat loss.

Warnings

DO NOT INJECT MORE THAN ONCE PER WEEK. Not suitable under 18 / during pregnancy / while breastfeeding. Common side effects: nausea, indigestion, constipation or diarrhoea. Always consult a healthcare professional. Disposable pen option is R50 extra.

Storage

Refrigerate at 2-8°C. DO NOT FREEZE.

Administration

Subcutaneous injection. Compatible with pen-injectors or insulin syringes.

Kit Contents

1 x Tirzepatide 30mg Cartridge

Related Products

Retatrutide | GLP-1 Peptide